Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a ...

When Twist Bioscience last reported its March 2025 balance sheet in May 2025, it had zero debt and cash worth US$257m. Importantly, its cash burn was US$65m over the trailing twelve months.

Twist Bioscience Twist Bioscience is a synthetic biology company that has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. Twist Bioscience works in the ...

The global DNA data storage market size was valued at USD 77.56 million in 2024 and is poised to grow from USD 124.59 million by 2025 to reach USD 5524.86 million by 2033, reflecting a robust CAGR ...

How Well Is Twist Bioscience Growing? We reckon the fact that Twist Bioscience managed to shrink its cash burn by 31% over the last year is rather encouraging. And considering that its operating ...

Find the latest Twist Bioscience Corporation (TWST) stock quote, history, news and other vital information to help you with your stock trading and investing.

It follows a previous report showing that the Werner syndrome protein WRN and its interacting protein WRNIP1 are indispensable for translesion DNA synthesis (TLS) by Y-family DNA polymerases (Pols).

Review Twist Bioscience Corp (TWST:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.

Review the current Twist Bioscience Corp (TWST:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if TWST is the best investment for you.

DNA synthesis is the biological process by which a deoxyribonucleic acid (DNA) molecule is created. In the cell, each of the two strands of the DNA molecule acts as a template for the synthesis of ...